Pay in 4 interest-free payments of $28.50 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
(2000)68 79
Solubility: DMSO : 100 mg/mL (246
Glut1 deficiency syndrome and erythrocyte glucose uptake assay
Clin Cancer Res 2014
1459687-96-7
Betrixaban 40551 (2000)68 79Betrixaban, also known as PRT054021, MK 4448; PRT 021; PRT 054021; MLN 1021, is a potent, orally active and highly selective factor Xa inhibitor undergone human clinical trials for prevention of embolism after knee surgery, and prevention of stroke following atrial fibrillation. Betrixaban is currently being studied in a human clinical trial for extended duration thromboprophylaxis to prevent venous thromboembolism in acute medically ill patients.